Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced clear cell renal cell (HCRN GU16-260-Cohort A): Final report

Atkins, Michael B. ; Jegede, Opeyemi ; Haas, Naomi B. ; McDermott, David F. ; Bilen, Mehmet Asim ; Stein, Mark N. ; Sosman, Jeffrey Alan ; Alter, Robert S. ; Plimack, Elizabeth R. ; Ornstein, Moshe Chaim ; Hurwitz, Michael E. ; Peace, David J. ; Signoretti, Sabina ; Denize, Thomas ; Cimadamore, Alessia ; Braun, David A. ; Wu, Catherine J. ; Einstein, David Johnson ; Catalano, Paul J. ; Hammers, Hans J.

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.288-288 [Revista revisada por pares]

Texto completo disponible